CIK 0001080014 · Large accelerated filer
Innoviva, Inc.
Sign in to watch- Ticker
- INVA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943265960
- Phone
- 6502389600
- Business address
- 1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
- Former names
- THERAVANCE INC, ADVANCED MEDICINE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-15 | Zhen Marianne Chief Accounting Officer | Grant or award | +1,576 | 52,721 | ||
| 2023-05-11 | DENNER ALEXANDER J 10% owner | Purchase | +290,000 | $12.34 | $3.6M | 6,904,000 |
| 2023-04-13 | Zhen Marianne Chief Accounting Officer | Grant or award | +14,344 | 51,145 | ||
| 2023-04-13 | Zhen Marianne Chief Accounting Officer | Grant or award · Non-statutory Stock Option | +20,000 | 40,000 | ||
| 2023-03-10 | Raifeld Pavel Chief Executive Officer | Purchase | +3,000 | $10.87 | $33K | 9,799 |
| 2023-02-17 | Zhen Marianne Chief Accounting Officer | Shares withheld for taxes | −1,852 | $12.42 | $23K | 36,801 |
| 2022-11-18 | Zhen Marianne Chief Accounting Officer | Shares withheld for taxes | −828 | $13.55 | $11K | 38,653 |
| 2022-11-15 | Zhen Marianne Chief Accounting Officer | Grant or award | +433 | 39,481 | ||
| 2022-08-19 | Zhen Marianne Chief Accounting Officer | Shares withheld for taxes | −830 | $14.12 | $12K | 39,048 |
| 2022-05-20 | Zhen Marianne Chief Accounting Officer | Shares withheld for taxes | −828 | $16.29 | $13K | 39,878 |
| 2022-05-13 | Zhen Marianne Chief Accounting Officer | Grant or award | +1,834 | 40,706 | ||
| 2022-05-02 | Raifeld Pavel Chief Executive Officer | Grant or award · Nonstatutory Stock Option | +150,000 | 500,000 | ||
| 2022-04-25 | Birx Deborah Director | Grant or award | +12,647 | 42,489 | ||
| 2022-04-25 | Birx Deborah Director | Grant or award · Non-statutory Stock Option | +10,000 | 10,000 | ||
| 2022-04-25 | Bickerstaff George Director | Grant or award | +12,647 | 137,207 | ||
| 2022-04-25 | Bickerstaff George Director | Grant or award · Non-statutory Stock Option | +10,000 | 10,000 | ||
| 2022-04-25 | Haimovitz Jules Director | Grant or award | +12,647 | 100,411 | ||
| 2022-04-25 | Haimovitz Jules Director | Grant or award · Non-statutory Stock Option | +10,000 | 10,000 | ||
| 2022-04-25 | DiPaolo Mark Director | Grant or award | +12,647 | 88,211 | ||
| 2022-04-25 | DiPaolo Mark Director | Grant or award · Non-statutory Stock Option | +10,000 | 10,000 |
Page 7 of 10 · 181 trades